Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
US6638727B1 · kind B1 · utility
25Cited by
15References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 1999 |
| Grant date | Oct 28, 2003 |
| Priority date | — |
| Expiry date | May 17, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/723
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is to methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or therapeutically treating these asymptomatic patients, and methods for monitoring the treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.